Anavex Life Sciences Corporation (NASDAQ: AVXL) is -1.40% lower on its value in year-to-date trading and has touched a low of $3.25 and a high of $10.45 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The AVXL stock was last observed hovering at around $8.46 in the last trading session, with the day’s gains setting it 0.72%.
Currently trading at $9.18, the stock is 6.22% and 25.25% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.54 million and changing 8.51% at the moment leaves the stock 65.61% off its SMA200. AVXL registered 4.56% gain for a year compared to 6-month gain of 146.11%. The firm has a 50-day simple moving average (SMA 50) of $7.2577 and a 200-day simple moving average (SMA200) of $5.523775.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 14.32% loss in the last 1 month and extending the period to 3 months gives it a 68.13%, and is 10.60% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 7.57% over the week and 9.08% over the month.
Anavex Life Sciences Corporation (AVXL) has around 40 employees, a market worth around $793.43M and $0.00M in sales. Distance from 52-week low is 182.46% and -12.15% from its 52-week high. The company has generated returns on investments over the last 12 months (-31.98%).
The EPS is expected to grow by 9.44% this year, but quarterly earnings will post 0.00% year-over-year. Quarterly sales are estimated to shrink 0.00% in year-over-year returns.
Anavex Life Sciences Corporation (AVXL) Top Institutional Holders
189.0 institutions hold shares in Anavex Life Sciences Corporation (AVXL), with institutional investors hold 33.04% of the company’s shares. The shares outstanding are 84.80M, and float is at 82.10M with Short Float at 23.99%. Institutions hold 32.04% of the Float.
The top institutional shareholder in the company is BLACKROCK INC. with over 6.39 million shares valued at $26.97 million. The investor’s holdings represent 7.7506% of the AVXL Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 4.55 million shares valued at $19.19 million to account for 5.5154 of the shares outstanding. The other top investors are STATE STREET CORP which holds 3.74 million shares representing 4.5357% and valued at over $15.78 million, while GEODE CAPITAL MANAGEMENT, LLC holds 2.2207 of the shares totaling 1.83 million with a market value of $7.73 million.
Anavex Life Sciences Corporation (AVXL) Insider Activity
The most recent transaction is an insider purchase by Donhauser Peter D.O., the company’s Director. SEC filings show that Donhauser Peter D.O. bought 2,835 shares of the company’s common stock on Jun 14 ’24 at a price of $3.64 per share for a total of $10319.0. Following the purchase, the insider now owns 5000.0 shares.
Anavex Life Sciences Corporation disclosed in a document filed with the SEC on May 15 ’24 that Thomas Steffen (Director) bought a total of 5,000 shares of the company’s common stock. The trade occurred on May 15 ’24 and was made at $4.52 per share for $22600.0. Following the transaction, the insider now directly holds 5000.0 shares of the AVXL stock.
Still, SEC filings show that on Mar 28 ’24, MISSLING CHRISTOPHER U (President and CEO) disposed off 73,380 shares at an average price of $5.11 for $0.37 million. The insider now directly holds 1,250,210 shares of Anavex Life Sciences Corporation (AVXL).
